Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

331.00p
   
  • Change Today:
      10.50p
  • 52 Week High: 470.00
  • 52 Week Low: 166.80
  • Currency: UK Pounds
  • Shares Issued: 100.00m
  • Volume: 229,494
  • Market Cap: £331.00m
  • RiskGrade: 125

Deal with Barclays    Trade now with Barclays Stockbrokers

OXB Overview

Oxford Biomedica develops innovative new IP-protected , LentiVector® based therapies, leveraging our internal research expertise and know-how. We select patient-centric product candidates and progress these through proof-of-concept, and into early clinical development, before either seeking third-party funding for full development and commercialisation or to develop further in-house.
Registrars: Capita Registrars

Key Personnel

CEO: Frank Mathias
CFO: Stuart Paynter
Chairman and CEO: Roch Doliveux
Independent Non-Executive Director: Leone Patterson
Independent Non-Executive Director: Catherine Moukheibir
Independent Non-Executive Director: Namrata P Patel
Independent Non-Executive Director: Heather Preston
Senior Independent Director: Dame Kay Davies
Vice Chairman: Stuart Henderson
Non-Executive Dir: Peter Soelkner, Michael Hayden, Robert Ghenchev

Contact Details

Address: Windrush Court, Transport Way, Oxford, United Kingdom, OX4 6LT
Phone: +44 (0) 1865 783 000
Fax: +44 (0) 1865 783 001
Website: http://www.oxb.com/

Listings

Sector: Pharma and Biotech(LSE)
Index: techMARK, FTSE Small Cap, FTSE All-Share, FTSE techMARK Focus
Overseas Listings: BATSLON:OXBL
ISIN: GB00BDFBVT43

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 331.00p
Change Today 10.50p
% Change 3.28 %
52 Week High 470.00
52 Week Low 166.80
Volume 229,494
Shares Issued 100.00m
Market Cap £331.00m
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
27.26% below the market average27.26% below the market average27.26% below the market average27.26% below the market average27.26% below the market average
21.57% above the sector average21.57% above the sector average21.57% above the sector average21.57% above the sector average21.57% above the sector average
Price Trend
1.33% below the market average1.33% below the market average1.33% below the market average1.33% below the market average1.33% below the market average
37.04% above the sector average37.04% above the sector average37.04% above the sector average37.04% above the sector average37.04% above the sector average
Income Not Available
Growth
52.07% below the market average52.07% below the market average52.07% below the market average52.07% below the market average52.07% below the market average
60% below the sector average60% below the sector average60% below the sector average60% below the sector average60% below the sector average

What The Brokers Say

Strong Buy 1
Buy 3
Neutral 5
Sell 0
Strong Sell 0
Total 9
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 31-May-2024

Time Volume / Share Price
16:41 19,813 @ 331.00p
16:35 66,721 @ 331.00p
16:35 61 @ 331.00p
16:35 87 @ 331.00p
16:35 138 @ 331.00p

OXB Key Personnel

CFO Stuart Paynter
CEO Frank Mathias

Top of Page